4.81

1.43% -0.07

After Hours: 4.81

Treace Medical Concepts Inc (TMCI)

Overview News Price History Option Chain Financials Discussions Forecast

Treace Medical Concepts Inc stock is traded at $4.81, with a volume of 231.83K. It is down -1.43% in the last 24 hours and up +1.48% over the past month. Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

Previous Close:

$4.88

Open:

$4.82

24h Volume:

231.83K

Relative Volume:

0.36

Market Cap:

$312.82M

Revenue:

$207.32M

Net Income/Loss:

$-61.04M

P/E Ratio:

-5.0224

EPS:

-0.9577

Net Cash Flow:

$-25.97M

1W Performance:

+3.44%

1M Performance:

+1.48%

6M Performance:

+227.21%

1Y Performance:

-32.91%

1-Day Range:

$4.72

$4.89

1-Week Range:

$4.55

$4.93

52-Week Range:

$1.17

$7.63

Treace Medical Concepts Inc Stock (TMCI) Company Profile

Name

Treace Medical Concepts Inc

Sector

Healthcare (1074)

Industry

Medical Devices (141)

Phone

(904) 373-5940

Address

100 PALMETTO PARK PLACE, PONTE VEDRA

Employee

450

Twitter

Next Earnings Date

2026-08-07

Latest SEC Filings

TMCI's Discussions on Twitter

Compare TMCI vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMCI Treace Medical Concepts Inc	4.81	290.05M	207.32M	-61.04M	-25.97M	-0.9577
ABT Abbott Laboratories	108.33	197.51B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	94.17	118.14B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	303.13	125.70B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	47.80	71.55B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.90	51.78B	6.30B	1.07B	1.09B	1.8406

Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-07-25	Downgrade	BTIG Research	Buy → Neutral
Nov-07-25	Downgrade	JP Morgan	Neutral → Underweight
Feb-04-25	Upgrade	BTIG Research	Neutral → Buy
Dec-31-24	Initiated	Lake Street	Buy
Dec-17-24	Resumed	JP Morgan	Neutral
May-16-24	Downgrade	UBS	Buy → Neutral
May-08-24	Downgrade	BTIG Research	Buy → Neutral
May-08-24	Downgrade	JP Morgan	Overweight → Neutral
May-08-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
May-08-24	Downgrade	Stifel	Buy → Hold
May-08-24	Downgrade	Truist	Buy → Hold
Sep-29-23	Initiated	UBS	Buy
May-01-23	Initiated	Truist	Buy
Apr-11-23	Initiated	Stephens	Equal-Weight
May-12-22	Initiated	BTIG Research	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-18-21	Initiated	JP Morgan	Overweight
May-18-21	Initiated	Morgan Stanley	Equal-Weight
May-18-21	Initiated	SVB Leerink	Outperform
May-18-21	Initiated	Stifel	Buy

View All

Treace Medical Concepts Inc Stock (TMCI) Latest News

Sep 06, 2026

BlackRock Inc. Takes Position in Treace Medical Concepts, Inc. $TMCI - MarketBeat

Sep 06, 2026

Sep 05, 2026

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat

Sep 05, 2026

Aug 30, 2026

Treace Medical (TMCI) Holds Gains: Stock Rises 1.09% as $4.42 Support Anchors the ChartMerger Arbitrage - vinanet.vn

Aug 30, 2026

Aug 29, 2026

Bank of America Corp DE Has $4.31 Million Stock Holdings in Treace Medical Concepts, Inc. $TMCI - MarketBeat

Aug 29, 2026

Aug 28, 2026

Treace Medical Concepts (TMCI) Gains 0.87% as Shares Approach Key Resistance at $4.87Trend Reversal Picks - siam.in

Aug 28, 2026

Weber Capital Management LLC ADV Invests $2.35 Million in Treace Medical Concepts, Inc. $TMCI - MarketBeat

Aug 28, 2026

Aug 26, 2026

SNDL And 2 Other Promising Penny Stocks To Watch - simplywall.st

Aug 26, 2026

Aug 24, 2026

Treace Medical (TMCI) CEO adds to stake with late‑August buys - Stock Titan

Aug 24, 2026

Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace Acquires 39,944 Shares of Stock - MarketBeat

Aug 24, 2026

Aug 20, 2026